{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:26:56Z","timestamp":1787063216731,"version":"build-2736575974"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    A 64-year-old man was referred because of the right ureteral obstruction. CT urography showed an intraluminal enhancing mass in the right midureter and an enhancing nodule in the bladder wall. FDG PET\/CT showed increased FDG uptake of the ureteral mass and an unexpected hypermetabolic lesion in the jejunum. The patient underwent transurethral resection of the bladder tumor, right laparoscopic nephroureterectomy, and partial enterectomy. Inverted urothelial papilloma of the bladder, high-grade urothelial carcinoma of the right ureter, and jejunal adenocarcinoma were confirmed by histopathology. Genetic testing of the jejunal adenocarcinoma revealed\n                    <jats:italic toggle=\"yes\">MSH2<\/jats:italic>\n                    germline mutation, confirming the diagnosis of Lynch syndrome.\n                  <\/jats:p>","DOI":"10.1097\/rlu.0000000000003779","type":"journal-article","created":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T02:03:51Z","timestamp":1624673031000},"page":"e11-e13","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["FDG PET\/CT in a Case of Lynch Syndrome With Synchronous Inverted Urothelial Papilloma of the Bladder, Urothelial Carcinoma of the Ureter, and Jejunal Adenocarcinoma"],"prefix":"10.1097","volume":"47","author":[{"given":"Qian","family":"Zhao","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine, General Hospital of Ningxia Medical University, Yinchuan, Ningxia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisheng","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Changhai Hospital, Navy Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Shanghai Fourth People\u2019s Hospital Affiliated to Tongji University School of Medicine, Shanghai, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,6,25]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1148\/rg.2015140209","article-title":"CT urography for evaluation of the ureter","volume":"35","year":"2015","journal-title":"Radiographics"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1148\/rg.2018170075","article-title":"Lynch syndrome: genomics update and imaging review","volume":"38","year":"2018","journal-title":"Radiographics"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1001\/jama.2011.743","article-title":"Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in lynch syndrome","volume":"305","year":"2011","journal-title":"JAMA"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.urology.2019.07.004","article-title":"Lynch syndrome in urologic malignancies\u2014what does the urologist need to know?","volume":"134","year":"2019","journal-title":"Urology"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S1470-2045(08)70232-8","article-title":"Small-bowel cancer in lynch syndrome: is it time for surveillance?","volume":"9","year":"2008","journal-title":"Lancet Oncol"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1007\/s12328-020-01147-y","article-title":"Double small bowel cancers leading to the diagnosis of lynch syndrome with germline MSH6 mutation in an elderly patient","volume":"13","year":"2020","journal-title":"Clin J Gastroenterol"},{"key":"bib7-20250621","first-page":"3847672","article-title":"Prolonged treatment response to pembrolizumab in a patient with pretreated metastatic colon cancer and lynch syndrome","volume":"2019","year":"2019","journal-title":"Case Rep Oncol Med"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"222","DOI":"10.4103\/1450-1147.161728","article-title":"Lynch syndrome associated colon adenocarcinoma resembling lymphoma on fluoro-deoxyglucose-positron emission tomography\/computed tomography","volume":"14","year":"2015","journal-title":"World J Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003779","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T16:07:15Z","timestamp":1750522035000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003779"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,25]]},"references-count":8,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000003779","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6,25]]}}}